Cancer Research and Treatment

Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial

Elton Trigo Teixeira Leite, Clarissa Cerchi Angotti Ramos, Victor Augusto Bertotti Ribeiro, Bernardo Peres Salvajoli, William Carlos Nahas, João Victor Salvajoli, Fabio Ynoe Moraes

International Journal of Radiation Oncology*Biology*Physics.2021; 109(5): 1263. CrossRef

Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance

Olayinka A. Abiodun-Ojo, Ashesh B. Jani, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Oluwaseun A. Odewole, Funmilayo I. Tade, Shreyas S. Joshi, Viraj A. Master, Bridget Fielder, Raghuveer K. Halkar, Chao Zhang, Subir Goyal, Mark M. Goodman, David M.

Journal of Nuclear Medicine.2021; 62(8): 1089. CrossRef

Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis

Changhoon Song, Sang Jun Byun, Young Seok Kim, Hanjong Ahn, Seok-Soo Byun, Choung-Soo Kim, Sang Eun Lee, Jae-Sung Kim, Christopher J.D. Wallis

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial

Christian Carrie, Nicolas Magné, Patricia Burban-Provost, Paul Sargos, Igor Latorzeff, Jean-Léon Lagrange, Stéphane Supiot, Yazid Belkacemi, Didier Peiffert, Nedla Allouache, Bernard M Dubray, Stéphanie Servagi-Vernat, Jean-Philippe Suchaud, Gilles Crehan

Clinical impact of PSMA-based 18F–DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy

Esther Mena, Maria L. Lindenberg, Joanna H. Shih, Stephen Adler, Stephanie Harmon, Ethan Bergvall, Deborah Citrin, William Dahut, Anita T. Ton, Yolanda McKinney, Juanita Weaver, Philip Eclarinal, Alicia Forest, George Afari, Sibaprasad Bhattacharyya, Ronn

European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(1): 4. CrossRef

Recent advances in radiation oncology: multimodal targeting of high risk and recurrent prostate cancer

Young Kwok, Adeel Kaiser, Stephanie R. Rice, Randi Cohen, Mark Mishra

Current Opinion in Oncology.2018; 30(3): 165. CrossRef

Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer

Oladunni O. Akin-Akintayo, Ashesh B. Jani, Oluwaseun Odewole, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Leah M. Bellamy, Raghuveer K. Halkar, Chao Zhang, Zhengjia Chen, Mark M. Goodman, David M. Schuster

Clinical Nuclear Medicine.2017; 42(1): e22. CrossRef

The Trend of Uro-Oncologist About Blood Test and Imaging Studies for the Diagnosis of Biochemical Recurrence in Korea

Sung Pil Seo, Won Tae Kim, Ho Won Kang, Yong-June Kim, Sang-Cheol Lee, Wun-Jae Kim, So Young Kim, Jong-Hyock Park, Seok Joong Yun

The Korean Journal of Urological Oncology.2017; 15(3): 131. CrossRef

Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy

Wan Song, Hwang Gyun Jeon, Hyun Hwan Sung, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han Yong Choi, Hyun Moo Lee

International Journal of Urology.2016; 23(1): 56. CrossRef

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial

Christian Carrie, Ali Hasbini, Guy de Laroche, Pierre Richaud, Stéphane Guerif, Igor Latorzeff, Stéphane Supiot, Mathieu Bosset, Jean-Léon Lagrange, Véronique Beckendorf, François Lesaunier, Bernard Dubray, Jean-Philippe Wagner, Tan Dat N'Guyen, Jean-Phil

Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial

Eduard Schreibmann, David M. Schuster, Peter J. Rossi, Joseph Shelton, Sherrie Cooper, Ashesh B. Jani

International Journal of Radiation Oncology*Biology*Physics.2016; 96(1): 206. CrossRef

Detection of a second malignancy in prostate cancer patients by using [18F]Choline PET/CT: a case series

Martina Sollini, Francesco Pasqualetti, Marzio Perri, Gabriele Coraggio, Paolo Castellucci, Massimo Roncali, Roberto Boni, Elena Lazzeri, Maria Galeandro, Fabiola Paiar, Annibale Versari, Paola Anna Erba

Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells

Xiaofang Wang, Wenjuan Zhang, Zi Yan, Yupei Liang, Lihui Li, Xiaoli Yu, Yan Feng, Shen Fu, Yanmei Zhang, Hu Zhao, Jinha Yu, Lak Shin Jeong, Xiaomao Guo, Lijun Jia

Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study

Takashi Mizowaki, Manabu Aoki, Katsumasa Nakamura, Atsunori Yorozu, Masaki Kokubo, Katsuyuki Karasawa, Takuyo Kozuka, Nobuaki Nakajima, Keisuke Sasai, Tetsuo Akimoto

Journal of Radiation Research.2015; 56(4): 750. CrossRef

Utilization of PSA measurement at three months following salvage radiation therapy to predict future biochemical outcome

Michael G. Heckman, Katherine S. Tzou, Colleen S. Thomas, Thomas M. Pisansky, Steven E. Schild, William W. Wong, Richard J. Lee, Melanie C. Bois, Waleed Brinjikji, Jennifer L. Peterson, Larry C. Daugherty, Stephen J. Ko, Steven J. Buskirk

Journal of Radiation Oncology.2014; 3(1): 81. CrossRef

Anti-3-[ 18 F]FACBC Positron Emission Tomography-Computerized Tomography and 111 In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prosta

David M. Schuster, Peter T. Nieh, Ashesh B. Jani, Rianot Amzat, F. DuBois Bowman, Raghuveer K. Halkar, Viraj A. Master, Jonathon A. Nye, Oluwaseun A. Odewole, Adeboye O. Osunkoya, Bital Savir-Baruch, Pooneh Alaei-Taleghani, Mark M. Goodman

Salvage Low-Dose-Rate Brachytherapy for Prostate Cancer Local Recurrence after Radical Prostatectomy: Our First three Patients

Emilio Gastaldi, Fabrizio Gallo, Luciano Chiono, Claudio Giberti

Lack of association between COX-2 staining level and biochemical recurrence following salvage radiation therapy for recurrent prostate cancer

Michael G. Heckman, Katherine S. Tzou, Alexander S. Parker, Thomas M. Pisansky, Steven E. Schild, Tracy W. Hilton, Vivek N. Patel, Liset Pelaez, Li Yan Khor, Jennifer L. Peterson, Larry C. Daugherty, Laura A. Vallow, Alan Pollack, Steven J. Buskirk

Journal of Radiation Oncology.2013; 2(3): 309. CrossRef

Treatment of men with rising prostate-specific antigen levels following radical prostatectomy

Expert Review of Anticancer Therapy.2011; 11(1): 125. CrossRef

Detection of Recurrent Prostate Carcinoma withanti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and111In–Capromab Pendetide SPECT/CT

David M. Schuster, Bital Savir-Baruch, Peter T. Nieh, Viraj A. Master, Raghuveer K. Halkar, Peter J. Rossi, Melinda M. Lewis, Jonathon A. Nye, Weiping Yu, F. DuBois Bowman, Mark M. Goodman

EUS-guided fiducial placement after radical prostatectomy before targeted radiation therapy for prostate cancer recurrence

Gastrointestinal Endoscopy.2011; 73(6): 1302. CrossRef